Clover Health Investments (CLOV) Announces Resignation of Nathaniel S. Turner from Board
Tweet
Share
E-mail
Get Alerts CLOV Hot Sheet
Join SI Premium – FREE
On May 26, 2022, Nathaniel S. Turner resigned as a member of the Board of Directors of Clover Health Investments (NASDAQ: CLOV). Mr. Turner’s resignation as a director was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bristol-Myers Squibb (BMY) stock slips despite earnings beat
- Sportradar (SRAD) Appoints Craig Felenstein as CFO
- OptiNose (OPTN) Provides Corporate Update on XHANCE Launch
Create E-mail Alert Related Categories
Board Changes, Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
